Optometrist · New York, NY
NPI
1861047649
Since 2019
Specialty
Optometrist
Code 152W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
2204 Frederick Douglass Blvd
New York, NY, 10026
Phone (732) 379-2339
Groups this clinician bills Medicare through
Medicare paid, 2023
$14K
179 services
Medicare patients, 2023
37
Average age 72
Drug cost, 2024
$951K
1,519 prescriptions
Company payments, 2025
$818
From 8 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Brittni C Rodriguez was code 92012 (ophthalmological e&m), 37 times for 19 patients. In total Brittni C Rodriguez billed 179 services in 17 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 37 | 19 | $72.41 | $2,679 |
| 92004 Ophthalmological E&M | Office | 26 | 26 | $129.36 | $3,363 |
| 92250 Angiography | Office | 26 | 26 | $32.42 | $843 |
| 92083 Vision, Hearing, and Speech Services | Office | 13 | 13 | $57.22 | $744 |
By year: 2022 $6,955 for 112 services; 2023 $14K for 179 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brittni C Rodriguez prescribed most often to Medicare patients was Restasis (Cyclosporine), with 461 prescriptions and refills. In total Brittni C Rodriguez wrote 1,519 Medicare prescriptions that cost $951K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 461 | 677 | 154 | $405K |
| Xiidra Lifitegrast | 201 | 268 | 62 | $177K |
| Lumigan Bimatoprost | 171 | 263 | 56 | $69K |
| Miebo Perfluorohexyloctane/Pf | 138 | 155 | 65 | $113K |
| Restasis Multidose Cyclosporine | 93 | 127 | 33 | $74K |
| Latanoprost Generic | 75 | 110 | 23 | $633 |
| Eysuvis Loteprednol Etabonate | 69 | 76 | 57 | $36K |
| Cyclosporine Generic | 62 | 101 | 32 | $27K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 29 | 29 | 17 | $296 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 28 | 38 | Under 11 | $13K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 27 | 37 | Under 11 | $317 |
| Combigan Brimonidine Tartrate/Timolol | 27 | 51 | 11 | $12K |
| Azelastine Hcl Generic | 24 | 24 | Under 11 | $425 |
| Prednisolone Acetate Generic | 23 | 29 | 20 | $811 |
| Timolol Maleate Generic | 15 | 24 | Under 11 | $266 |
Brand drugs: 1,318 claims; generic drugs: 201 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brittni C Rodriguez $818 ($818 in general payments such as food, travel and fees) from 8 companies. The largest payer was Alcon Vision LLC with $345.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 22 | $345 |
| CooperVision Inc. COO | 2 | $125 |
| Bausch & Lomb Americas Inc. BLCO | 6 | $119 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $81.27 |
| Oyster Point Pharma, Inc. | 3 | $70.16 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $35.6 |
| Dompe US, Inc. | 1 | $23.8 |
| Harrow Eye, LLC | 1 | $17.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.